SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, reaffirms its position as the leader in chronic lymphocytic leukemia (CLL) ...

According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved pirtobrutinib for certain adults with relapsed or refractory chronic lymphocytic leukemia ...

Jaypirca is approved for CLL/SLL patients previously treated with covalent BTK inhibitors, offering a new treatment option. The BRUIN-CLL-321 trial showed Jaypirca improved progression-free survival ...

Lymphocytic colitis is a bowel condition characterized by chronic, watery diarrhea and the buildup of white blood cells in your gut. It is most common in older adults. Lymphocytic colitis is a rare ...

Ménétrier’s disease is a rare, progressive disorder of unclear etiology, typically affecting middle-aged men and characterized by giant gastric mucosal folds, mainly in the fundus and body, with ...

Hulk Hogan secretly battled leukemia before his death, Page Six has exclusively learned. The late wrestling legend had a history of chronic lymphocytic leukemia (CLL), per a report from the Pinellas ...

In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, ...

Look, if you’ve dealt with gastritis, you already know that big meals feel like torture. There’s actually science behind why – research shows that stomach inflammation can make larger meals ...

Senior Lecturer of Exercise Immunology, Faculty of Health and Medical Sciences, School of Biosciences, University of Surrey CLL starts when a type of immune cell called a B cell – normally responsible ...

Personalized exercise guidance is needed for people living with Chronic Lymphocytic Leukemia (CLL), the most common type of blood cancer, according to a new study led by the University of Surrey. The ...